Zdrowie i gospodarka · 09/07/2015
FDA Releases Draft Guidance on Heparin-Containing Medical Devices and Combination Products
The FDA has released a draft guidance outlining new labeling and safety testing requirements for heparin-containing medical devices and combination products, aiming to address safety concerns related to the revised USP monographs.
Source: Federal Register — Food and Drug AdministrationOpen original release →